Pathophysiology during neural information processing in ADHD

Klinik für Psychiatrie und Psychotherapie der Uniklinik Köln0 sites32 target enrollmentJuly 18, 2018

Overview

No summary available.

Registry

who.int

Start Date

July 18, 2018

End Date

TBD

Last Updated

last year

Study Type

Observational

Sex

All

Sponsor

Klinik für Psychiatrie und Psychotherapie der Uniklinik Köln

•Amendment 1\+2:
•1\) Age 18\-45
•2\) Sufficient understanding of the German language for the questionnaire survey
•3\) Written informed consent of patients
•4\) Diagnosis of ADHD according to ICD\-10
•5\) Clinically indicated treatment with methylphenidate
•6\) Stable psychotropic medication (except ADHD medication) for at least 4 weeks
•Amendment 1:
•unmedicated, concerning methylphenidate
•Amendment 2:

•1\. known neurological disorders affecting the brain, including condition after craniocerebral trauma with unconsciousness greater than 5 minutes
•2\. harmful substance use according to ICD\-10
•3\. taking antipsychotics up to 4 weeks before baseline and during the examination period
•For Amendment 1:
•4\. taking pharmaceuticals for ADHD treatment on the day of the examination (not extended release) or within 48 hours (extended release and atomoxetine) before baseline
•For Amendment 2:
•4\. taking pharmaceuticals for ADHD treatment on the day of the examination (not extemded release) or within 48 hours (extended release and atomoxetine) before baseline, with the exception of methylphenidate
•5\. motor hyperactivity at the time of measurement that makes an EEG examination impossible
•6\. known IQ \< 70
•7\. premature birth \< 32 wks